Vitamix Blending Containers and Blade Bases recalled due to Laceration Hazard, USA
1 week ago •source cpsc.gov • details
Recall notice
1 year ago •source fda.gov
Recall notice
United States
Mylan Pharmaceuticals Inc., a Viatris company, is voluntarily recalling one batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), 3 mL prefilled pens which are packaged in cartons of five pens to the consumer level. This product is not the branded Semglee® pen but the unbranded Insulin Glargine-yfgn pens. This batch is being recalled due to the potential for the label to be missing on some pens. This batch was manufactured by Biocon Sdn. Bhd. and was distributed by Mylan Specialty L.P. in the US between April 4, 2022 and May 5, 2022. To date, no adverse events related to this recall have been received for this product.1 week ago •source cpsc.gov • details
Recall notice
2 weeks ago •reported by user-zrnp2455 • details
4 weeks ago •reported by user-zdxz2354 • details
3 weeks ago •reported by user-jcjdx649 • details
3 weeks ago •reported by user-cfdj9429 • details
5 days ago •reported by user-hngcb485 • details
1 week ago •reported by user-gqzzq737 • details
2 weeks ago •source fda.gov • details
Recall notice
2 weeks ago •reported by user-kqcdq213 • details
1 week ago •reported by user-tknbk285 • details
Search